Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus?

Bacteraemia caused by Staphylococcus aureus infections can lead to life-threatening metastatic infections. Thwaites and Gant propose that neutrophils form a privileged site that is poorly accessible to antibiotics and that plays an important part in transporting the bacteria to distant sites. Staphy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature reviews. Microbiology Jg. 9; H. 3; S. 215 - 222
Hauptverfasser: Thwaites, Guy E., Gant, Vanya
Format: Journal Article
Sprache:Englisch
Veröffentlicht: London Nature Publishing Group UK 01.03.2011
Nature Publishing Group
Schlagworte:
ISSN:1740-1526, 1740-1534, 1740-1534
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Bacteraemia caused by Staphylococcus aureus infections can lead to life-threatening metastatic infections. Thwaites and Gant propose that neutrophils form a privileged site that is poorly accessible to antibiotics and that plays an important part in transporting the bacteria to distant sites. Staphylococcus aureus bacteraemia remains very difficult to treat, and a large proportion of cases result in potentially lethal metastatic infection. Unpredictable and persistent bacteraemia in the face of highly active, usually bactericidal antibiotics is the strongest predictor of death or disseminated disease. Although S. aureus has conventionally been considered an extracellular pathogen, much evidence demonstrates that it can survive intracellularly. In this Opinion article, we propose that phagocytes, and specifically neutrophils, represent a privileged site for S. aureus in the bloodstream, offering protection from most antibiotics and providing a mechanism by which the bacterium can travel to and infect distant sites. Furthermore, we suggest how this can be experimentally confirmed and how it may prompt a change in the current paradigm of S. aureus bacteraemia and identify better treatment options for improved clinical outcomes.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Feature-3
content type line 23
ObjectType-Review-2
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1740-1526
1740-1534
1740-1534
DOI:10.1038/nrmicro2508